Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008

N. R. V. Jones, C. M. Fischbacher, B. Guthrie, G. Leese, R. S. Lindsay, J. A. McKnight, D. Pearson, S. Philip, N. Sattar, S. H. Wild (Lead / Corresponding author), Scottish Diabetes Research Network Epidemiology Group

    Research output: Contribution to journalArticlepeer-review

    11 Citations (Scopus)
    136 Downloads (Pure)

    Abstract

    Aim: To describe characteristics associated with statin prescribing for the primary prevention of cardiovascular disease in people with newly diagnosed diabetes. Methods: Data from the Scottish Care Information-Diabetes Collaboration data set for 2006-2008 were used. This data set contains socio-demographic and prescribing data for over 99% of people with diagnosed diabetes in Scotland. Analyses were conducted on people aged over 40 years diagnosed with Type 1 or Type 2 diabetes between 2006 and 2008 with complete data and no previous history of cardiovascular or statin prescription. Logistic regression was used to calculate odds ratios for statin prescription in the 2 years following diagnosis of diabetes. Results: There were 7157 men and 5601 women who met the inclusion criteria, 68% of whom had a statin prescription recorded in the 2 years following diagnosis of diabetes. The proportions receiving statins were lower above 65 years of age in men and 75 years of age in women. People with Type 1 diabetes had lower odds of receiving statins than people with Type 2 diabetes [odds ratio (95% CI) 0.42 (0.29-0.61) for men and 0.48 (0.28-0.81) for women, after adjustment for age, BMI, smoking status, cholesterol level and deprivation]. Higher total cholesterol, BMI and being a current smoker were associated with greater odds of statin prescription. Conclusion: Approximately one third of the study population had no record of statin prescription during the 2 years after diagnosis of diabetes. Cardiovascular disease risk reduction opportunities may be missed in some of these people.
    Original languageEnglish
    Pages (from-to)640-646
    Number of pages7
    JournalDiabetic Medicine
    Volume31
    Issue number6
    DOIs
    Publication statusPublished - Jun 2014

    Fingerprint

    Dive into the research topics of 'Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008'. Together they form a unique fingerprint.

    Cite this